Blood tumour mutational burden and response to pembrolizumab plus chemotherapy in non-small cell lung cancer

Avelumab plus platinum-based chemotherapy may show some efficacy in patients with extensive-stage small cell lung cancer

Addition of atezolizumab to chemotherapy after surgery does not improve survival for triple negative breast cancer

A combined PET-MRI scan could improve treatment for patients with early breast cancer

EBCC 2024: Addressing inequalities across Europe in access to innovation for patients with metastatic breast cancer

Comment: EBCC 2024 highlights

Saruparib shows encouraging efficacy and safety in mutant advanced solid tumours

Linvoseltamab induces deep and durable responses in patients with relapsed or refractory multiple myeloma

Darolutamide, androgen-deprivation therapy and docetaxel demonstrate promising efficacy mHSPC

Blood test may identify patients with non-small cell lung cancer subtype who can benefit from combination therapy

Mirvetuximab soravtansine and pembrolizumab combo shows promise in endometrial cancer subtype

EAU 2024: Bladder cancer latest